Exelixis Statistics
Total Valuation
Exelixis has a market cap or net worth of $11.06 billion. The enterprise value is $9.67 billion.
| Market Cap | 11.06B |
| Enterprise Value | 9.67B |
Important Dates
The last earnings date was Tuesday, November 4, 2025, after market close.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Exelixis has 269.20 million shares outstanding. The number of shares has decreased by -4.93% in one year.
| Current Share Class | 269.20M |
| Shares Outstanding | 269.20M |
| Shares Change (YoY) | -4.93% |
| Shares Change (QoQ) | -2.06% |
| Owned by Insiders (%) | 1.73% |
| Owned by Institutions (%) | 81.92% |
| Float | 229.13M |
Valuation Ratios
The trailing PE ratio is 17.28 and the forward PE ratio is 13.83. Exelixis's PEG ratio is 0.49.
| PE Ratio | 17.28 |
| Forward PE | 13.83 |
| PS Ratio | 4.96 |
| Forward PS | 4.25 |
| PB Ratio | 5.10 |
| P/TBV Ratio | 5.27 |
| P/FCF Ratio | 14.18 |
| P/OCF Ratio | 13.98 |
| PEG Ratio | 0.49 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.37, with an EV/FCF ratio of 12.40.
| EV / Earnings | 14.26 |
| EV / Sales | 4.22 |
| EV / EBITDA | 11.37 |
| EV / EBIT | 11.78 |
| EV / FCF | 12.40 |
Financial Position
The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.75 |
| Quick Ratio | 3.50 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.20 |
| Debt / FCF | 0.23 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 30.56% and return on invested capital (ROIC) is 21.33%.
| Return on Equity (ROE) | 30.56% |
| Return on Assets (ROA) | 17.73% |
| Return on Invested Capital (ROIC) | 21.33% |
| Return on Capital Employed (ROCE) | 33.48% |
| Revenue Per Employee | $1.99M |
| Profits Per Employee | $591,023 |
| Employee Count | 1,147 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 3.19 |
Taxes
In the past 12 months, Exelixis has paid $195.39 million in taxes.
| Income Tax | 195.39M |
| Effective Tax Rate | 22.37% |
Stock Price Statistics
The stock price has increased by +16.78% in the last 52 weeks. The beta is 0.40, so Exelixis's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +16.78% |
| 50-Day Moving Average | 40.69 |
| 200-Day Moving Average | 39.93 |
| Relative Strength Index (RSI) | 43.85 |
| Average Volume (20 Days) | 2,587,896 |
Short Selling Information
The latest short interest is 20.15 million, so 7.48% of the outstanding shares have been sold short.
| Short Interest | 20.15M |
| Short Previous Month | 19.79M |
| Short % of Shares Out | 7.48% |
| Short % of Float | 8.79% |
| Short Ratio (days to cover) | 6.37 |
Income Statement
In the last 12 months, Exelixis had revenue of $2.29 billion and earned $677.90 million in profits. Earnings per share was $2.38.
| Revenue | 2.29B |
| Gross Profit | 2.21B |
| Operating Income | 820.25M |
| Pretax Income | 873.29M |
| Net Income | 677.90M |
| EBITDA | 850.00M |
| EBIT | 820.25M |
| Earnings Per Share (EPS) | $2.38 |
Balance Sheet
The company has $988.54 million in cash and $176.46 million in debt, giving a net cash position of $1.39 billion or $5.16 per share.
| Cash & Cash Equivalents | 988.54M |
| Total Debt | 176.46M |
| Net Cash | 1.39B |
| Net Cash Per Share | $5.16 |
| Equity (Book Value) | 2.16B |
| Book Value Per Share | 8.06 |
| Working Capital | 1.03B |
Cash Flow
In the last 12 months, operating cash flow was $791.02 million and capital expenditures -$11.25 million, giving a free cash flow of $779.77 million.
| Operating Cash Flow | 791.02M |
| Capital Expenditures | -11.25M |
| Free Cash Flow | 779.77M |
| FCF Per Share | $2.90 |
Margins
Gross margin is 96.63%, with operating and profit margins of 35.85% and 29.63%.
| Gross Margin | 96.63% |
| Operating Margin | 35.85% |
| Pretax Margin | 38.16% |
| Profit Margin | 29.63% |
| EBITDA Margin | 37.15% |
| EBIT Margin | 35.85% |
| FCF Margin | 34.08% |
Dividends & Yields
Exelixis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.93% |
| Shareholder Yield | 4.93% |
| Earnings Yield | 6.13% |
| FCF Yield | 7.05% |
Analyst Forecast
The average price target for Exelixis is $44.73, which is 8.91% higher than the current price. The consensus rating is "Buy".
| Price Target | $44.73 |
| Price Target Difference | 8.91% |
| Analyst Consensus | Buy |
| Analyst Count | 24 |
| Revenue Growth Forecast (5Y) | 7.49% |
| EPS Growth Forecast (5Y) | 20.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exelixis has an Altman Z-Score of 11.47 and a Piotroski F-Score of 6.
| Altman Z-Score | 11.47 |
| Piotroski F-Score | 6 |